| Changing patterns of secondary preventive medication among newly diagnosed coronary heart disease patients with diabetes in Finland: a register-based study. | |
| | |
MedLine Citation:
|
PMID: 20228159 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIMS: Information on medicine use among coronary heart disease (CHD) patients with diabetes in unselected patient populations is scarce. This study examines the use of medication to prevent new cardiac events among newly diagnosed CHD patients with diabetes comparing them to patients without diabetes and examines socioeconomic differences in medicine use in these patient groups. METHODS: Data on CHD patients (43,501 men and 31,125 women) with or without diabetes were individually linked from nationwide registers (covering both patients treated in ambulatory and in hospital inpatient care). Age-standardised rates for medication use were calculated and differences between patient groups examined using Poisson regression. RESULTS: beta-blocker use was high in all patient groups in 1997-2002, angiotensin-converting enzyme (ACE) inhibitor and angiotensin II antagonist use increased and remained higher among patients with diabetes. More than half of men and women with diabetes used ACE inhibitors and one out of five used angiotensin II antagonists in 2002. Lipid-lowering medication use increased, especially among women. In 1997-98 it was lower in lower socioeconomic groups; among men with diabetes the use remained lower than among others. CONCLUSIONS: beta-blocker use was constant and ACE inhibitor and angiotensin II antagonist use increased. Lipid-lowering medication use increased considerably after a health insurance reform in 2000, in which elevated reimbursement of drug costs (75%) was extended to include all CHD patients with hyperlipidaemia.Socioeconomic differences in medication use disappeared after the reform. However, lipid-lowering medication use remained at a lower level among men with diabetes, suggesting that their treatment did not follow guidelines. |
| | |
Authors:
|
Tuulikki Vehko; Kristna Manderbacka; Martti Arffman; Reijo Sund; Antti Reunanen; Ilmo Keskim?ki |
Related Documents
:
|
10564549 - Changes in plasma apolipoprotein ai and aii concentrations in murine reactive amyloidosis. 18845649 - Comparison of the performance of saps ii, saps 3, apache ii, and their customized progn... 22612579 - Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in pati... 12136399 - Impaired no-dependent vasodilation in patients with type ii (non-insulin-dependent) dia... 18238849 - The role of sgk-1 in angiotensin ii-mediated sodium reabsorption in human proximal tubu... 22519919 - Imeglimin, a novel glimin oral anti-diabetic, exhibits a good efficacy and safety profi... 16284079 - Rapid glucose sensing by protein kinase a for insulin exocytosis in mouse pancreatic is... 22069259 - Multiple antigens versus single major antigen in type 1 diabetes: arguing for multiple ... 18437349 - Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secre... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't Date: 2010-03-12 |
Journal Detail:
|
Title: Scandinavian journal of public health Volume: 38 ISSN: 1651-1905 ISO Abbreviation: Scand J Public Health Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-03 Completed Date: 2010-05-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883503 Medline TA: Scand J Public Health Country: Sweden |
Other Details:
|
Languages: eng Pagination: 317-24 Citation Subset: IM |
Affiliation:
|
National Institute for Health and Welfare (THL), Helsinki, Finland. tuulikki.vehko@thl.fi |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
administration & dosage Adult Aged Angiotensin II Type 1 Receptor Blockers / administration & dosage Angiotensin-Converting Enzyme Inhibitors / administration & dosage Antilipemic Agents / administration & dosage Coronary Disease / diagnosis, etiology, prevention & control* Diabetes Mellitus, Type 1 / complications, drug therapy* Diabetes Mellitus, Type 2 / complications, drug therapy* Drug Prescriptions / economics, statistics & numerical data Drug Utilization / economics, statistics & numerical data Female Finland Humans Male Middle Aged Practice Guidelines as Topic Registries Reimbursement Mechanisms Secondary Prevention* Socioeconomic Factors |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Antilipemic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Locality differences of sickness absence in the context of health and social conditions of the inhab...
Next Document: Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol ...